Maravai CFO has 5,466 shares withheld for taxes
A separate 126,352-share transfer from direct ownership to his family trust was exempt from reporting under Rule 16a-13.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Maravai LifeSciences Holdings, Inc. Chief Financial Officer Rajesh Asarpota had 5,466 shares of Class A common stock withheld on October 30, 2026, to satisfy tax-withholding obligations tied to vesting restricted stock unit awards; the reported price was $8.46 per share. Following the transaction, he beneficially owned 286,203 shares directly and 126,352 shares indirectly through his family trust.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Class A Common Stock F1, F2 | 5,466 | $8.46 | $46K |
| Holding | Class A Common Stock F2 | -- | -- | -- |
Footnotes (2)
- F1. Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person.
- F2. The shares of Class A Common Stock beneficially owned by the reporting person directly and indirectly following the transaction reported herein reflect a transfer of 126,352 shares previously reported as directly owned by the reporting person to the reporting person's family trust, which transfer of shares was exempt from reporting pursuant to Rule 16a-13.
Key Figures
Key Terms
restricted stock unit awards financial
tax withholding obligations financial
Rule 16a-13 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.